Detalhe da pesquisa
1.
Artificial intelligence and machine learning in axial spondyloarthritis.
Curr Opin Rheumatol
; 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38533807
2.
Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres.
Ann Rheum Dis
; 83(2): 184-193, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37890976
3.
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial.
Ann Rheum Dis
; 83(5): 599-607, 2024 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38228361
4.
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.
Ann Rheum Dis
; 83(5): 547-549, 2024 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38071514
5.
Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapy.
Rheumatology (Oxford)
; 2024 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38507706
6.
Characterization of bone marrow lesions in axial spondyloarthritis using quantitative T1 mapping MRI.
Skeletal Radiol
; 53(7): 1295-1302, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38224381
7.
Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany.
Z Rheumatol
; 83(Suppl 1): 20-30, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36749363
8.
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 400(10349): 369-379, 2022 07 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35908570
9.
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.
Ann Rheum Dis
; 82(2): 212-216, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36100350
10.
ASAS consensus definition of early axial spondyloarthritis.
Ann Rheum Dis
; 2023 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37321799
11.
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials.
Ann Rheum Dis
; 82(4): 515-526, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36649967
12.
Instrument selection for the ASAS core outcome set for axial spondyloarthritis.
Ann Rheum Dis
; 82(6): 763-772, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35680390
13.
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ann Rheum Dis
; 82(1): 19-34, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36270658
14.
New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT.
Rheumatology (Oxford)
; 62(12): 3893-3898, 2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37018132
15.
Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritis.
Rheumatology (Oxford)
; 62(3): 1117-1123, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35532084
16.
Treating spondyloarthritis early: does it matter? Results from a systematic literature review.
Rheumatology (Oxford)
; 62(4): 1398-1409, 2023 04 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36099043
17.
Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort.
Rheumatology (Oxford)
; 62(4): 1631-1635, 2023 04 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35951746
18.
Self-reported diagnostic confidence predicts diagnostic accuracy in axial spondyloarthritis imaging.
Rheumatology (Oxford)
; 2023 Oct 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37882740
19.
Regional differences in clinical phenotype of axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS).
Rheumatology (Oxford)
; 2023 Dec 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38128022
20.
[Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version]. / Systematisches Review zur Schätzung der Prävalenz entzündlich rheumatischer Erkrankungen in Deutschland.
Z Rheumatol
; 82(9): 727-738, 2023 Nov.
Artigo
Alemão
| MEDLINE | ID: mdl-36592211